Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association.
Saved in:
| Title: | Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association. |
|---|---|
| Authors: | Neumiller JJ; Department of Pharmacotherapy, Washington State University, Spokane, WA., Bajaj M; Department of Medicine, Baylor College of Medicine, Houston, TX., Bannuru RR; American Diabetes Association, Arlington, VA., McCoy RG; Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD., Pekas EJ; American Diabetes Association, Arlington, VA., Segal AR; Massachusetts College of Pharmacy and Health Sciences, Boston, MA., ElSayed NA; American Diabetes Association, Arlington, VA.; Harvard Medical School, Boston, MA. |
| Source: | Diabetes care [Diabetes Care] 2025 Feb 01; Vol. 48 (2), pp. 177-181. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
